NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Comparison of automated versus vacuum-assisted biopsy methods for sonographically guided core biopsy of the breast.

Author(s): Philpotts LE, Hooley RJ, Lee CH

Publication: AJR Am J Roentgenol, 2003, Vol. 180, Page 347-51

PubMed ID: 12540431 PubMed Review Paper? No

Purpose of Paper

This paper compared the diagnostic accuracy and reasons for request of rebiopsy of 14-gauge (G) automated gun and 11-G vacuum-assisted device (VAD) breast biopsies.

Conclusion of Paper

Rebiopsy either immediately or at follow-up were necessary for a comparable number of non-malignant cases obtained with a 14-G automated gun and a 11-G VAD. Importantly, the reasons for rebiopsy and the false negative and underestimation rates were also comparable.  Final diagnosis was based on follow-up or histology of the excisional specimen. 

Studies

  1. Study Purpose

    This study compared the diagnostic accuracy and reasons for request of rebiopsy of 14-G automated gun and 11-G VAD breast biopsies. One hundred eighty-one biopsies were obtained from 177 patients with a 14-G automated gun and 100 biopsies from 94 patients with an 11-G VAD. The incidence of each diagnosis was comparable between the two biopsy types, indicating biopsy type was blind.

    Summary of Findings:

    Rebiopsy was recommended for a comparable number of non-malignant cases biopsied with each device. Further, rebiopsy was most often requested because of discordance between imaging and histology biopsy for both 14-G biopsies and 11-G VAD biopsies (56% and 65%, respectively), followed by identification of a high risk lesion (20% and 18%, respectively). Insufficient sample was obtained with the 14-G biopsy in 3 cases (12%) and with the 11-G VAD in 1 case (6%), but this difference was not significant. Further, rebiopsy revealed only one false-negative for each biopsy method. After excision of 54 suspicious lesions, the underestimation rate of 14-G and 11-G VAD specimens were comparable (0% and 1%, respectively). Further, the rate at which a second biopsy was requested during follow-up because of growth was comparable for the two devices (2.5% for 14-G and 3% for 11-G VAD) and none of these cases were later determined to be false-negatives.

    Biospecimens
    Preservative Types
    • Formalin
    Diagnoses:
    • Neoplastic - Benign
    • Neoplastic - Carcinoma
    Platform:
    AnalyteTechnology Platform
    Morphology Light microscopy
    Morphology H-and-E microscopy
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Acquisition Method of tissue acquisition Vacuum assisted biopsy
    Core needle biopsy
    Biospecimen Acquisition Needle gauge 14-G
    11-G

You Recently Viewed  

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • More...